Hong Shi
About Hong Shi
Hong Shi is a Clinical Trial Physician in Oncology at Bristol Myers Squibb in Princeton, New Jersey, with extensive experience in toxicology, cardiovascular safety, and obstetrics and gynecology.
Current Role at Bristol Myers Squibb
Hong Shi is currently serving as a Clinical Trial Physician, Oncology at Bristol Myers Squibb in Princeton, New Jersey. In this hybrid role, she focuses on clinical trials in the field of oncology, contributing to the development and testing of new cancer treatments. Her work involves coordination with various teams to ensure the effective execution of clinical studies, adhering to regulatory requirements and upholding patient safety.
Previous Positions at Bristol Myers Squibb
Prior to her current position, Hong Shi held various roles at Bristol Myers Squibb. She worked as a Senior Principal Scientist in Discovery Toxicology for five months from 2021 to 2022. Simultaneously, she had a nine-month rotational role as a Clinical Trial Physician in Oncology from 2021 to 2022. These roles allowed her to leverage her expertise in toxicology and oncology to advance drug discovery and clinical trial execution.
Professional Experience at Pfizer
Hong Shi's career includes a notable tenure at Pfizer from 2000 to 2001, where she served as an Assistant Research Scientist in Cardiovascular Safety for ten months. During this time, she developed a novel assay for evaluating drug-induced cardiotoxicity, which contributed to safer pharmaceutical development. Her research at Pfizer also garnered a research grant from the National Institutes of Health (NIH).
Educational Background and Training
Hong Shi's medical and scientific expertise is underpinned by her educational background from Shanghai Second Medical University, where she earned her MD in Medicine between 1984 and 1990. She later honed her research skills during a fellowship at the Montreal Heart Institute, where she worked in Electrophysiology, Pharmacology, and Molecular Biology from 1997 to 2000. This diverse training has equipped her with a holistic understanding of medical sciences and clinical research.
Research and Publications
Hong Shi has authored several peer-reviewed articles in the fields of oncology and toxicology. She has presented her research findings at prominent international conferences, including the American Society of Clinical Oncology (ASCO). Her contributions to scientific literature and her active presence at conferences highlight her commitment to advancing medical knowledge and sharing breakthroughs with the global scientific community.